Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6388790 | 0.81 | TAAR1 (0.39) | F2TAAR1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL53374 | 0.77 | TAAR1 (0.37) | F2TAAR1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL3951516 | 0.77 | TAAR1 (0.37) | TAAR1RIPK1SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL11770112 | 0.76 | TAAR1 (0.40) | TAAR1RIPK1SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL7074781 | 0.74 | TAAR1 (0.39) | TAAR1RIPK1SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL2212637 | 0.73 | RIPK1 (0.40) | F2TAAR1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL118483 | 0.73 | F2 (0.43) | F2TAAR1RIPK1SLC6A4SLC6A3 | |
| SCHEMBL11770121 | 0.72 | SLC6A4 (0.39) | TAAR1RIPK1SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL29022132 | 0.72 | TSHR (0.34) | TAAR1RIPK1SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL5029899 | 0.72 | RIPK1 (0.43) | F2TAAR1RIPK1SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284162-A | Synthesis and preparation method of lycium barbarum acid | 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） | 2023-06-23 | — | — | CN | claimed |
| US-20070244322-A1 | Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin | MERCK EPROVA AG (CH) | 2007-10-18 | — | — | US | claimed |
| EP-1776364-A2 | PROCESSES FOR PREPARING TETRAHYDROBIOPTERIN, AND ANALOGS OF TETRAHYDROBIOPTERIN | BioMarin Pharmaceutical Inc. (US) | 2007-04-25 | — | — | EP | claimed |
| WO-2005049614-A2 | PROCESSES FOR PREPARING TETRAHYDROBIOPTERIN, AND ANALOGS OF TETRAHYDROBIOPTERIN | BIOMARIN PHARMACEUTICAL INC. (US) | 2005-06-02 | — | — | WO | claimed |
| CN-116284162-A | Synthesis and preparation method of lycium barbarum acid | 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） | 2023-06-23 | — | — | CN | disclosed |
| CN-106795186-B | Process for preparing morpholino oligonucleotides | 味之素株式会社 | 2021-03-02 | — | — | CN | disclosed |
| US-7732599-B2 | from neopterin and/or 6-substituted pterins with improved yield and high stereoselectivity; reduction catalysts | BIOMARIN PHARMACEUTICAL INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-20070244322-A1 | Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin | MERCK EPROVA AG (CH) | 2007-10-18 | — | — | US | disclosed |
| EP-1776364-A2 | PROCESSES FOR PREPARING TETRAHYDROBIOPTERIN, AND ANALOGS OF TETRAHYDROBIOPTERIN | BioMarin Pharmaceutical Inc. (US) | 2007-04-25 | — | — | EP | disclosed |
| WO-2005049614-A2 | PROCESSES FOR PREPARING TETRAHYDROBIOPTERIN, AND ANALOGS OF TETRAHYDROBIOPTERIN | BIOMARIN PHARMACEUTICAL INC. (US) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244322-A1 | Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin | SPR, DHPS, BLVRB | F2 902/4885TAAR1 2206/4885RIPK1 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.